Antidepressive-like effect of a Kampo (traditional Japanese) medicine, kososan (Xiang Su San) in a stress-induced depression-like mouse model: Proteomic analysis of hypothalamus

Traditional and Kampo Medicine

Volumn 2, Issue 2, 2015, Pages 50-59

  Nagai, Takayuki ^a   Hashimoto, Ryoko ^a   Okuda, Sari M ^a   Kodera, Yoshio ^a   Oh Ishi, Masamichi ^a   Maeda, Tadakazu ^a   Ito, Naoki ^a   Hanawa, Toshihiko ^a   Kiyohara, Hiroaki ^a   Yamada, Haruki ^a,b  

^a KITASATO UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

2 ,3 cyclic nucleotide 3 phosphodiesterase; antidepressant; kososan; metabotropic glutamate receptor 2; proteomic analysis; Xiang Su San

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE 1; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE 2; ANTIDEPRESSANT AGENT; KAMPO; KOSOSAN; METABOTROPIC RECEPTOR 2; MILNACIPRAN; UNCLASSIFIED DRUG;

AGAROSE TWO DIMENSIONAL GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN FORNIX; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; FORCED SWIM TEST; GEL ELECTROPHORESIS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; IMMOBILITY; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; RECEPTOR DOWN REGULATION; STRESS; TRADITIONAL MEDICINE; TREATMENT OUTCOME; UPREGULATION; WESTERN BLOTTING;

EID: 85018987489     PISSN: None     EISSN: 20534515     Source Type: Journal    
DOI: 10.1002/tkm2.1018     Document Type: Article

References (27)

1. Hanawa T. Kososan and Hangekobokuto. J. Kampo Med. 1995; 42: 418–426.
2. Ito N, Nagai T, Yabe T, Nunome S, Hanawa T, Yamada H. Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis. Phytomedicine 2006; 13: 658–667.
3. Nagai T, Narikawa T, Ito N, Takeda T, Hanawa T, Yamada H. Antidepressant-like effect of a Kampo (Japanese herbal) medicine, kososan, against the interferon-α-induced depressive-like model mice. J. Tradit. Med. 2008; 25: 74–80.
4. Ito N, Yabe T, Nagai T, Oikawa T, Yamada H, Hanawa T. A possible mechanism underlying an antidepressive-like effect of Kososan, a Kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice. Biol. Pharm. Bull. 2009; 32: 1716–1722.
5. Ito N, Hori A, Yabe T et al. Involvement of neuropeptide Y signaling in the antidepressant-like effect and hippocampal cell proliferation induced by kososan, a Kampo medicine, in the stress-induced depression-like model mice. Biol. Pharm. Bull. 2012; 35: 1775–1783.
6. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: A primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 1977; 229: 327–336.
7. Detke MJ, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp. Clin. Psychopharmacol. 1997; 5: 107–112.
8. Solberg LC, Horton TH, Turek FW. Circadian rhythms and depression: Effects of exercise in an animal model. Am. J. Physiol. 1999; 276: R152–R161.
9. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl.) 1987; 93: 358–364.
10. Oh-Ishi M, Satoh M, Maeda T. Preparative two-dimensional gel electrophoresis with agarose gels in the first dimension for high molecular mass proteins. Electrophoresis 2000; 21: 1653–1669.
11. Oh-Ishi M, Maeda T. Separation techniques for high-molecular-mass proteins. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002; 771: 49–66.
12. Oh-Ishi M, Maeda T. Disease proteomics of high-molecular-mass proteins by two-dimensional gel electrophoresis with agarose gels in the first dimension (Agarose 2-DE). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007; 849: 211–222.
13. Nagai T, Nakao M, Shimizu Y et al. Proteomic analysis of anti-inflammatory effects of a Kampo (Japanese herbal) medicine “shoseiryuto (xiao-qing-long-tang)” on airway inflammation in a mouse model. Evid. Based Complement. Altern. Med. 2011; 2011, Article ID 604196.
14. Sanagi T, Yabe T, Yamada H. Gene transfer of PEDF attenuates ischemic brain damage in the rat middle cerebral artery occlusion model. J. Neurochem. 2008; 106: 1841–1854.
15. Nicoletti F, Bockaert J, Collingridge GL et al. Metabotropic glutamate receptors: From the workbench to the bedside. Neuropharmacology 2011; 60: 1017–1041.
16. Matrisciano F, Panaccione I, Zusso M et al. Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: A new strategy to shorten the latency of antidepressant medication? Mol. Psychiatry 2007; 12: 704–706.
17. Matrisciano F, Caruso A, Orlando R et al. Defective group-II metabotropic glutamate receptors in the hippocampus of spontaneously depressed rats. Neuropharmacology 2008; 55: 525–531.
18. Chaki S, Ago Y, Palucha-Paniewiera A, Matrisciano F, Pilc A. mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants. Neuropharmacology 2013; 66: 40–52.
19. Nasca C, Xenos D, Barone Y et al. l-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc. Natl. Acad. Sci. U. S. A. 2013; 110: 4804–4809.
20. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry 2005; 10: 309–322.
21. Sequeira A, Mamdani F, Ernst C et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009; 4: e6585.
22. Monoh K, Kurihara T, Sakimura K, Takahashi Y. Structure of mouse 2’,3’-cyclic-nucleotide 3’-phosphodiesterase gene. Biochem. Biophys. Res. Commun. 1989; 165: 1213–1220.
23. O'Neill RC, Minuk J, Cox ME, Braun PE, Gravel M. CNP2 mRNA directs synthesis of both CNP1 and CNP2 polypeptides. J. Neurosci. Res. 1997; 50: 248–257.
24. Mallei A, Giambelli R, Gass P et al. Synaptoproteomics of learned helpless rats involve energy metabolism and cellular remodeling pathways in depressive-like behavior and antidepressant response. Neuropharmacology 2011; 60: 1243–1253.
25. Miyake N, Yano S, Sakai C et al. Mitochondrial complex III deficiency caused by a homozygous UQCRC2 mutation presenting with neonatal-onset recurrent metabolic decompensation. Hum. Mutat. 2013; 34: 446–452.
26. Manoli I, Alesci S, Blackman MR, Su YA, Rennert OM, Chrousos GP. Mitochondria as key components of the stress response. Trends Endocrinol. Metab. 2007; 18: 190–198.
27. Green D, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626–629.